Global Lidocaine Transdermal Patch Market Growth 2025-2031
The global Lidocaine Transdermal Patch market size is predicted to grow from US$ 216 million in 2025 to US$ 260 million in 2031; it is expected to grow at a CAGR of 3.1% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Lidocaine is chemically known as acetamide, 2- (diethylamino) -n - (2, 6-dimethyl phenyl), octanol at pH 7.4;Moisture ratio for 43, lidocaine transdermal patch is suitable for adults and adolescents 12 years of age or temporary pain relief including 5% lidocaine transdermal patches, 1.8% lidocaine transdermal patches, 4% lidocaine transdermal patches containing 5%, 1.8% and 4% respectively of lidocaine adhesive materials, the material paste on nonwoven polyester felt backing, and covered with polyethylene terephthalate (PET) film stripping gasket, before the break on the skin, to remove off lining.
United States market for Lidocaine Transdermal Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Lidocaine Transdermal Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Lidocaine Transdermal Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Lidocaine Transdermal Patch players cover Teikoku, Teva Pharmaceutical, Sorrento Therapeutics, Hisamitsu, Endo International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Lidocaine Transdermal Patch Industry Forecast” looks at past sales and reviews total world Lidocaine Transdermal Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Lidocaine Transdermal Patch sales for 2025 through 2031. With Lidocaine Transdermal Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lidocaine Transdermal Patch industry.
This Insight Report provides a comprehensive analysis of the global Lidocaine Transdermal Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lidocaine Transdermal Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lidocaine Transdermal Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lidocaine Transdermal Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lidocaine Transdermal Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Lidocaine Transdermal Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Lidocaine Transdermal Patch market?
What factors are driving Lidocaine Transdermal Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lidocaine Transdermal Patch market opportunities vary by end market size?
How does Lidocaine Transdermal Patch break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Lidocaine is chemically known as acetamide, 2- (diethylamino) -n - (2, 6-dimethyl phenyl), octanol at pH 7.4;Moisture ratio for 43, lidocaine transdermal patch is suitable for adults and adolescents 12 years of age or temporary pain relief including 5% lidocaine transdermal patches, 1.8% lidocaine transdermal patches, 4% lidocaine transdermal patches containing 5%, 1.8% and 4% respectively of lidocaine adhesive materials, the material paste on nonwoven polyester felt backing, and covered with polyethylene terephthalate (PET) film stripping gasket, before the break on the skin, to remove off lining.
United States market for Lidocaine Transdermal Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Lidocaine Transdermal Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Lidocaine Transdermal Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Lidocaine Transdermal Patch players cover Teikoku, Teva Pharmaceutical, Sorrento Therapeutics, Hisamitsu, Endo International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Lidocaine Transdermal Patch Industry Forecast” looks at past sales and reviews total world Lidocaine Transdermal Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Lidocaine Transdermal Patch sales for 2025 through 2031. With Lidocaine Transdermal Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lidocaine Transdermal Patch industry.
This Insight Report provides a comprehensive analysis of the global Lidocaine Transdermal Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lidocaine Transdermal Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lidocaine Transdermal Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lidocaine Transdermal Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lidocaine Transdermal Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Lidocaine Transdermal Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Lidocare 5% Transdermal Patch
- Lidocare 1.80% Transdermal Patch
- Lidocare 4% Transdermal Patch
- Online Pharmacies
- Hospital Pharmacies
- Clinic
- Monomer Pharmacies
- Chain Pharmacies
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teikoku
- Teva Pharmaceutical
- Sorrento Therapeutics
- Hisamitsu
- Endo International
- Par Pharmaceutical
- Mylan
- Tide Pharmaceutical (SINO BIOPHARM)
What is the 10-year outlook for the global Lidocaine Transdermal Patch market?
What factors are driving Lidocaine Transdermal Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lidocaine Transdermal Patch market opportunities vary by end market size?
How does Lidocaine Transdermal Patch break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lidocaine Transdermal Patch Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Lidocaine Transdermal Patch by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Lidocaine Transdermal Patch by Country/Region, 2020, 2024 & 2031
2.2 Lidocaine Transdermal Patch Segment by Type
2.2.1 Lidocare 5% Transdermal Patch
2.2.2 Lidocare 1.80% Transdermal Patch
2.2.3 Lidocare 4% Transdermal Patch
2.3 Lidocaine Transdermal Patch Sales by Type
2.3.1 Global Lidocaine Transdermal Patch Sales Market Share by Type (2020-2025)
2.3.2 Global Lidocaine Transdermal Patch Revenue and Market Share by Type (2020-2025)
2.3.3 Global Lidocaine Transdermal Patch Sale Price by Type (2020-2025)
2.4 Lidocaine Transdermal Patch Segment by Application
2.4.1 Online Pharmacies
2.4.2 Hospital Pharmacies
2.4.3 Clinic
2.4.4 Monomer Pharmacies
2.4.5 Chain Pharmacies
2.4.6 Other
2.5 Lidocaine Transdermal Patch Sales by Application
2.5.1 Global Lidocaine Transdermal Patch Sale Market Share by Application (2020-2025)
2.5.2 Global Lidocaine Transdermal Patch Revenue and Market Share by Application (2020-2025)
2.5.3 Global Lidocaine Transdermal Patch Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Lidocaine Transdermal Patch Breakdown Data by Company
3.1.1 Global Lidocaine Transdermal Patch Annual Sales by Company (2020-2025)
3.1.2 Global Lidocaine Transdermal Patch Sales Market Share by Company (2020-2025)
3.2 Global Lidocaine Transdermal Patch Annual Revenue by Company (2020-2025)
3.2.1 Global Lidocaine Transdermal Patch Revenue by Company (2020-2025)
3.2.2 Global Lidocaine Transdermal Patch Revenue Market Share by Company (2020-2025)
3.3 Global Lidocaine Transdermal Patch Sale Price by Company
3.4 Key Manufacturers Lidocaine Transdermal Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lidocaine Transdermal Patch Product Location Distribution
3.4.2 Players Lidocaine Transdermal Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIDOCAINE TRANSDERMAL PATCH BY GEOGRAPHIC REGION
4.1 World Historic Lidocaine Transdermal Patch Market Size by Geographic Region (2020-2025)
4.1.1 Global Lidocaine Transdermal Patch Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Lidocaine Transdermal Patch Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Lidocaine Transdermal Patch Market Size by Country/Region (2020-2025)
4.2.1 Global Lidocaine Transdermal Patch Annual Sales by Country/Region (2020-2025)
4.2.2 Global Lidocaine Transdermal Patch Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lidocaine Transdermal Patch Sales Growth
4.4 APAC Lidocaine Transdermal Patch Sales Growth
4.5 Europe Lidocaine Transdermal Patch Sales Growth
4.6 Middle East & Africa Lidocaine Transdermal Patch Sales Growth
5 AMERICAS
5.1 Americas Lidocaine Transdermal Patch Sales by Country
5.1.1 Americas Lidocaine Transdermal Patch Sales by Country (2020-2025)
5.1.2 Americas Lidocaine Transdermal Patch Revenue by Country (2020-2025)
5.2 Americas Lidocaine Transdermal Patch Sales by Type (2020-2025)
5.3 Americas Lidocaine Transdermal Patch Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lidocaine Transdermal Patch Sales by Region
6.1.1 APAC Lidocaine Transdermal Patch Sales by Region (2020-2025)
6.1.2 APAC Lidocaine Transdermal Patch Revenue by Region (2020-2025)
6.2 APAC Lidocaine Transdermal Patch Sales by Type (2020-2025)
6.3 APAC Lidocaine Transdermal Patch Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lidocaine Transdermal Patch by Country
7.1.1 Europe Lidocaine Transdermal Patch Sales by Country (2020-2025)
7.1.2 Europe Lidocaine Transdermal Patch Revenue by Country (2020-2025)
7.2 Europe Lidocaine Transdermal Patch Sales by Type (2020-2025)
7.3 Europe Lidocaine Transdermal Patch Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lidocaine Transdermal Patch by Country
8.1.1 Middle East & Africa Lidocaine Transdermal Patch Sales by Country (2020-2025)
8.1.2 Middle East & Africa Lidocaine Transdermal Patch Revenue by Country (2020-2025)
8.2 Middle East & Africa Lidocaine Transdermal Patch Sales by Type (2020-2025)
8.3 Middle East & Africa Lidocaine Transdermal Patch Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lidocaine Transdermal Patch
10.3 Manufacturing Process Analysis of Lidocaine Transdermal Patch
10.4 Industry Chain Structure of Lidocaine Transdermal Patch
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lidocaine Transdermal Patch Distributors
11.3 Lidocaine Transdermal Patch Customer
12 WORLD FORECAST REVIEW FOR LIDOCAINE TRANSDERMAL PATCH BY GEOGRAPHIC REGION
12.1 Global Lidocaine Transdermal Patch Market Size Forecast by Region
12.1.1 Global Lidocaine Transdermal Patch Forecast by Region (2026-2031)
12.1.2 Global Lidocaine Transdermal Patch Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Lidocaine Transdermal Patch Forecast by Type (2026-2031)
12.7 Global Lidocaine Transdermal Patch Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Teikoku
13.1.1 Teikoku Company Information
13.1.2 Teikoku Lidocaine Transdermal Patch Product Portfolios and Specifications
13.1.3 Teikoku Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Teikoku Main Business Overview
13.1.5 Teikoku Latest Developments
13.2 Teva Pharmaceutical
13.2.1 Teva Pharmaceutical Company Information
13.2.2 Teva Pharmaceutical Lidocaine Transdermal Patch Product Portfolios and Specifications
13.2.3 Teva Pharmaceutical Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Pharmaceutical Main Business Overview
13.2.5 Teva Pharmaceutical Latest Developments
13.3 Sorrento Therapeutics
13.3.1 Sorrento Therapeutics Company Information
13.3.2 Sorrento Therapeutics Lidocaine Transdermal Patch Product Portfolios and Specifications
13.3.3 Sorrento Therapeutics Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sorrento Therapeutics Main Business Overview
13.3.5 Sorrento Therapeutics Latest Developments
13.4 Hisamitsu
13.4.1 Hisamitsu Company Information
13.4.2 Hisamitsu Lidocaine Transdermal Patch Product Portfolios and Specifications
13.4.3 Hisamitsu Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Hisamitsu Main Business Overview
13.4.5 Hisamitsu Latest Developments
13.5 Endo International
13.5.1 Endo International Company Information
13.5.2 Endo International Lidocaine Transdermal Patch Product Portfolios and Specifications
13.5.3 Endo International Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Endo International Main Business Overview
13.5.5 Endo International Latest Developments
13.6 Par Pharmaceutical
13.6.1 Par Pharmaceutical Company Information
13.6.2 Par Pharmaceutical Lidocaine Transdermal Patch Product Portfolios and Specifications
13.6.3 Par Pharmaceutical Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Par Pharmaceutical Main Business Overview
13.6.5 Par Pharmaceutical Latest Developments
13.7 Mylan
13.7.1 Mylan Company Information
13.7.2 Mylan Lidocaine Transdermal Patch Product Portfolios and Specifications
13.7.3 Mylan Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Mylan Main Business Overview
13.7.5 Mylan Latest Developments
13.8 Tide Pharmaceutical (SINO BIOPHARM)
13.8.1 Tide Pharmaceutical (SINO BIOPHARM) Company Information
13.8.2 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Product Portfolios and Specifications
13.8.3 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Tide Pharmaceutical (SINO BIOPHARM) Main Business Overview
13.8.5 Tide Pharmaceutical (SINO BIOPHARM) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lidocaine Transdermal Patch Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Lidocaine Transdermal Patch by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Lidocaine Transdermal Patch by Country/Region, 2020, 2024 & 2031
2.2 Lidocaine Transdermal Patch Segment by Type
2.2.1 Lidocare 5% Transdermal Patch
2.2.2 Lidocare 1.80% Transdermal Patch
2.2.3 Lidocare 4% Transdermal Patch
2.3 Lidocaine Transdermal Patch Sales by Type
2.3.1 Global Lidocaine Transdermal Patch Sales Market Share by Type (2020-2025)
2.3.2 Global Lidocaine Transdermal Patch Revenue and Market Share by Type (2020-2025)
2.3.3 Global Lidocaine Transdermal Patch Sale Price by Type (2020-2025)
2.4 Lidocaine Transdermal Patch Segment by Application
2.4.1 Online Pharmacies
2.4.2 Hospital Pharmacies
2.4.3 Clinic
2.4.4 Monomer Pharmacies
2.4.5 Chain Pharmacies
2.4.6 Other
2.5 Lidocaine Transdermal Patch Sales by Application
2.5.1 Global Lidocaine Transdermal Patch Sale Market Share by Application (2020-2025)
2.5.2 Global Lidocaine Transdermal Patch Revenue and Market Share by Application (2020-2025)
2.5.3 Global Lidocaine Transdermal Patch Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Lidocaine Transdermal Patch Breakdown Data by Company
3.1.1 Global Lidocaine Transdermal Patch Annual Sales by Company (2020-2025)
3.1.2 Global Lidocaine Transdermal Patch Sales Market Share by Company (2020-2025)
3.2 Global Lidocaine Transdermal Patch Annual Revenue by Company (2020-2025)
3.2.1 Global Lidocaine Transdermal Patch Revenue by Company (2020-2025)
3.2.2 Global Lidocaine Transdermal Patch Revenue Market Share by Company (2020-2025)
3.3 Global Lidocaine Transdermal Patch Sale Price by Company
3.4 Key Manufacturers Lidocaine Transdermal Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lidocaine Transdermal Patch Product Location Distribution
3.4.2 Players Lidocaine Transdermal Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIDOCAINE TRANSDERMAL PATCH BY GEOGRAPHIC REGION
4.1 World Historic Lidocaine Transdermal Patch Market Size by Geographic Region (2020-2025)
4.1.1 Global Lidocaine Transdermal Patch Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Lidocaine Transdermal Patch Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Lidocaine Transdermal Patch Market Size by Country/Region (2020-2025)
4.2.1 Global Lidocaine Transdermal Patch Annual Sales by Country/Region (2020-2025)
4.2.2 Global Lidocaine Transdermal Patch Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lidocaine Transdermal Patch Sales Growth
4.4 APAC Lidocaine Transdermal Patch Sales Growth
4.5 Europe Lidocaine Transdermal Patch Sales Growth
4.6 Middle East & Africa Lidocaine Transdermal Patch Sales Growth
5 AMERICAS
5.1 Americas Lidocaine Transdermal Patch Sales by Country
5.1.1 Americas Lidocaine Transdermal Patch Sales by Country (2020-2025)
5.1.2 Americas Lidocaine Transdermal Patch Revenue by Country (2020-2025)
5.2 Americas Lidocaine Transdermal Patch Sales by Type (2020-2025)
5.3 Americas Lidocaine Transdermal Patch Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lidocaine Transdermal Patch Sales by Region
6.1.1 APAC Lidocaine Transdermal Patch Sales by Region (2020-2025)
6.1.2 APAC Lidocaine Transdermal Patch Revenue by Region (2020-2025)
6.2 APAC Lidocaine Transdermal Patch Sales by Type (2020-2025)
6.3 APAC Lidocaine Transdermal Patch Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lidocaine Transdermal Patch by Country
7.1.1 Europe Lidocaine Transdermal Patch Sales by Country (2020-2025)
7.1.2 Europe Lidocaine Transdermal Patch Revenue by Country (2020-2025)
7.2 Europe Lidocaine Transdermal Patch Sales by Type (2020-2025)
7.3 Europe Lidocaine Transdermal Patch Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lidocaine Transdermal Patch by Country
8.1.1 Middle East & Africa Lidocaine Transdermal Patch Sales by Country (2020-2025)
8.1.2 Middle East & Africa Lidocaine Transdermal Patch Revenue by Country (2020-2025)
8.2 Middle East & Africa Lidocaine Transdermal Patch Sales by Type (2020-2025)
8.3 Middle East & Africa Lidocaine Transdermal Patch Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lidocaine Transdermal Patch
10.3 Manufacturing Process Analysis of Lidocaine Transdermal Patch
10.4 Industry Chain Structure of Lidocaine Transdermal Patch
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lidocaine Transdermal Patch Distributors
11.3 Lidocaine Transdermal Patch Customer
12 WORLD FORECAST REVIEW FOR LIDOCAINE TRANSDERMAL PATCH BY GEOGRAPHIC REGION
12.1 Global Lidocaine Transdermal Patch Market Size Forecast by Region
12.1.1 Global Lidocaine Transdermal Patch Forecast by Region (2026-2031)
12.1.2 Global Lidocaine Transdermal Patch Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Lidocaine Transdermal Patch Forecast by Type (2026-2031)
12.7 Global Lidocaine Transdermal Patch Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Teikoku
13.1.1 Teikoku Company Information
13.1.2 Teikoku Lidocaine Transdermal Patch Product Portfolios and Specifications
13.1.3 Teikoku Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Teikoku Main Business Overview
13.1.5 Teikoku Latest Developments
13.2 Teva Pharmaceutical
13.2.1 Teva Pharmaceutical Company Information
13.2.2 Teva Pharmaceutical Lidocaine Transdermal Patch Product Portfolios and Specifications
13.2.3 Teva Pharmaceutical Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Pharmaceutical Main Business Overview
13.2.5 Teva Pharmaceutical Latest Developments
13.3 Sorrento Therapeutics
13.3.1 Sorrento Therapeutics Company Information
13.3.2 Sorrento Therapeutics Lidocaine Transdermal Patch Product Portfolios and Specifications
13.3.3 Sorrento Therapeutics Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sorrento Therapeutics Main Business Overview
13.3.5 Sorrento Therapeutics Latest Developments
13.4 Hisamitsu
13.4.1 Hisamitsu Company Information
13.4.2 Hisamitsu Lidocaine Transdermal Patch Product Portfolios and Specifications
13.4.3 Hisamitsu Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Hisamitsu Main Business Overview
13.4.5 Hisamitsu Latest Developments
13.5 Endo International
13.5.1 Endo International Company Information
13.5.2 Endo International Lidocaine Transdermal Patch Product Portfolios and Specifications
13.5.3 Endo International Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Endo International Main Business Overview
13.5.5 Endo International Latest Developments
13.6 Par Pharmaceutical
13.6.1 Par Pharmaceutical Company Information
13.6.2 Par Pharmaceutical Lidocaine Transdermal Patch Product Portfolios and Specifications
13.6.3 Par Pharmaceutical Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Par Pharmaceutical Main Business Overview
13.6.5 Par Pharmaceutical Latest Developments
13.7 Mylan
13.7.1 Mylan Company Information
13.7.2 Mylan Lidocaine Transdermal Patch Product Portfolios and Specifications
13.7.3 Mylan Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Mylan Main Business Overview
13.7.5 Mylan Latest Developments
13.8 Tide Pharmaceutical (SINO BIOPHARM)
13.8.1 Tide Pharmaceutical (SINO BIOPHARM) Company Information
13.8.2 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Product Portfolios and Specifications
13.8.3 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Tide Pharmaceutical (SINO BIOPHARM) Main Business Overview
13.8.5 Tide Pharmaceutical (SINO BIOPHARM) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Lidocaine Transdermal Patch Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Lidocaine Transdermal Patch Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lidocare 5% Transdermal Patch
Table 4. Major Players of Lidocare 1.80% Transdermal Patch
Table 5. Major Players of Lidocare 4% Transdermal Patch
Table 6. Global Lidocaine Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 7. Global Lidocaine Transdermal Patch Sales Market Share by Type (2020-2025)
Table 8. Global Lidocaine Transdermal Patch Revenue by Type (2020-2025) & ($ million)
Table 9. Global Lidocaine Transdermal Patch Revenue Market Share by Type (2020-2025)
Table 10. Global Lidocaine Transdermal Patch Sale Price by Type (2020-2025) & (USD/K Pcs)
Table 11. Global Lidocaine Transdermal Patch Sale by Application (2020-2025) & (M Pcs)
Table 12. Global Lidocaine Transdermal Patch Sale Market Share by Application (2020-2025)
Table 13. Global Lidocaine Transdermal Patch Revenue by Application (2020-2025) & ($ million)
Table 14. Global Lidocaine Transdermal Patch Revenue Market Share by Application (2020-2025)
Table 15. Global Lidocaine Transdermal Patch Sale Price by Application (2020-2025) & (USD/K Pcs)
Table 16. Global Lidocaine Transdermal Patch Sales by Company (2020-2025) & (M Pcs)
Table 17. Global Lidocaine Transdermal Patch Sales Market Share by Company (2020-2025)
Table 18. Global Lidocaine Transdermal Patch Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Lidocaine Transdermal Patch Revenue Market Share by Company (2020-2025)
Table 20. Global Lidocaine Transdermal Patch Sale Price by Company (2020-2025) & (USD/K Pcs)
Table 21. Key Manufacturers Lidocaine Transdermal Patch Producing Area Distribution and Sales Area
Table 22. Players Lidocaine Transdermal Patch Products Offered
Table 23. Lidocaine Transdermal Patch Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Lidocaine Transdermal Patch Sales by Geographic Region (2020-2025) & (M Pcs)
Table 27. Global Lidocaine Transdermal Patch Sales Market Share Geographic Region (2020-2025)
Table 28. Global Lidocaine Transdermal Patch Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Lidocaine Transdermal Patch Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Lidocaine Transdermal Patch Sales by Country/Region (2020-2025) & (M Pcs)
Table 31. Global Lidocaine Transdermal Patch Sales Market Share by Country/Region (2020-2025)
Table 32. Global Lidocaine Transdermal Patch Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Lidocaine Transdermal Patch Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Lidocaine Transdermal Patch Sales by Country (2020-2025) & (M Pcs)
Table 35. Americas Lidocaine Transdermal Patch Sales Market Share by Country (2020-2025)
Table 36. Americas Lidocaine Transdermal Patch Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Lidocaine Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 38. Americas Lidocaine Transdermal Patch Sales by Application (2020-2025) & (M Pcs)
Table 39. APAC Lidocaine Transdermal Patch Sales by Region (2020-2025) & (M Pcs)
Table 40. APAC Lidocaine Transdermal Patch Sales Market Share by Region (2020-2025)
Table 41. APAC Lidocaine Transdermal Patch Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Lidocaine Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 43. APAC Lidocaine Transdermal Patch Sales by Application (2020-2025) & (M Pcs)
Table 44. Europe Lidocaine Transdermal Patch Sales by Country (2020-2025) & (M Pcs)
Table 45. Europe Lidocaine Transdermal Patch Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Lidocaine Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 47. Europe Lidocaine Transdermal Patch Sales by Application (2020-2025) & (M Pcs)
Table 48. Middle East & Africa Lidocaine Transdermal Patch Sales by Country (2020-2025) & (M Pcs)
Table 49. Middle East & Africa Lidocaine Transdermal Patch Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Lidocaine Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 51. Middle East & Africa Lidocaine Transdermal Patch Sales by Application (2020-2025) & (M Pcs)
Table 52. Key Market Drivers & Growth Opportunities of Lidocaine Transdermal Patch
Table 53. Key Market Challenges & Risks of Lidocaine Transdermal Patch
Table 54. Key Industry Trends of Lidocaine Transdermal Patch
Table 55. Lidocaine Transdermal Patch Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Lidocaine Transdermal Patch Distributors List
Table 58. Lidocaine Transdermal Patch Customer List
Table 59. Global Lidocaine Transdermal Patch Sales Forecast by Region (2026-2031) & (M Pcs)
Table 60. Global Lidocaine Transdermal Patch Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Lidocaine Transdermal Patch Sales Forecast by Country (2026-2031) & (M Pcs)
Table 62. Americas Lidocaine Transdermal Patch Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Lidocaine Transdermal Patch Sales Forecast by Region (2026-2031) & (M Pcs)
Table 64. APAC Lidocaine Transdermal Patch Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Lidocaine Transdermal Patch Sales Forecast by Country (2026-2031) & (M Pcs)
Table 66. Europe Lidocaine Transdermal Patch Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Lidocaine Transdermal Patch Sales Forecast by Country (2026-2031) & (M Pcs)
Table 68. Middle East & Africa Lidocaine Transdermal Patch Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Lidocaine Transdermal Patch Sales Forecast by Type (2026-2031) & (M Pcs)
Table 70. Global Lidocaine Transdermal Patch Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Lidocaine Transdermal Patch Sales Forecast by Application (2026-2031) & (M Pcs)
Table 72. Global Lidocaine Transdermal Patch Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Teikoku Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 74. Teikoku Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 75. Teikoku Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 76. Teikoku Main Business
Table 77. Teikoku Latest Developments
Table 78. Teva Pharmaceutical Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 79. Teva Pharmaceutical Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 80. Teva Pharmaceutical Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 81. Teva Pharmaceutical Main Business
Table 82. Teva Pharmaceutical Latest Developments
Table 83. Sorrento Therapeutics Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 84. Sorrento Therapeutics Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 85. Sorrento Therapeutics Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 86. Sorrento Therapeutics Main Business
Table 87. Sorrento Therapeutics Latest Developments
Table 88. Hisamitsu Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 89. Hisamitsu Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 90. Hisamitsu Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 91. Hisamitsu Main Business
Table 92. Hisamitsu Latest Developments
Table 93. Endo International Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 94. Endo International Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 95. Endo International Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 96. Endo International Main Business
Table 97. Endo International Latest Developments
Table 98. Par Pharmaceutical Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 99. Par Pharmaceutical Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 100. Par Pharmaceutical Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 101. Par Pharmaceutical Main Business
Table 102. Par Pharmaceutical Latest Developments
Table 103. Mylan Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 104. Mylan Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 105. Mylan Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 106. Mylan Main Business
Table 107. Mylan Latest Developments
Table 108. Tide Pharmaceutical (SINO BIOPHARM) Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 109. Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 110. Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 111. Tide Pharmaceutical (SINO BIOPHARM) Main Business
Table 112. Tide Pharmaceutical (SINO BIOPHARM) Latest Developments
Table 1. Lidocaine Transdermal Patch Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Lidocaine Transdermal Patch Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lidocare 5% Transdermal Patch
Table 4. Major Players of Lidocare 1.80% Transdermal Patch
Table 5. Major Players of Lidocare 4% Transdermal Patch
Table 6. Global Lidocaine Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 7. Global Lidocaine Transdermal Patch Sales Market Share by Type (2020-2025)
Table 8. Global Lidocaine Transdermal Patch Revenue by Type (2020-2025) & ($ million)
Table 9. Global Lidocaine Transdermal Patch Revenue Market Share by Type (2020-2025)
Table 10. Global Lidocaine Transdermal Patch Sale Price by Type (2020-2025) & (USD/K Pcs)
Table 11. Global Lidocaine Transdermal Patch Sale by Application (2020-2025) & (M Pcs)
Table 12. Global Lidocaine Transdermal Patch Sale Market Share by Application (2020-2025)
Table 13. Global Lidocaine Transdermal Patch Revenue by Application (2020-2025) & ($ million)
Table 14. Global Lidocaine Transdermal Patch Revenue Market Share by Application (2020-2025)
Table 15. Global Lidocaine Transdermal Patch Sale Price by Application (2020-2025) & (USD/K Pcs)
Table 16. Global Lidocaine Transdermal Patch Sales by Company (2020-2025) & (M Pcs)
Table 17. Global Lidocaine Transdermal Patch Sales Market Share by Company (2020-2025)
Table 18. Global Lidocaine Transdermal Patch Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Lidocaine Transdermal Patch Revenue Market Share by Company (2020-2025)
Table 20. Global Lidocaine Transdermal Patch Sale Price by Company (2020-2025) & (USD/K Pcs)
Table 21. Key Manufacturers Lidocaine Transdermal Patch Producing Area Distribution and Sales Area
Table 22. Players Lidocaine Transdermal Patch Products Offered
Table 23. Lidocaine Transdermal Patch Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Lidocaine Transdermal Patch Sales by Geographic Region (2020-2025) & (M Pcs)
Table 27. Global Lidocaine Transdermal Patch Sales Market Share Geographic Region (2020-2025)
Table 28. Global Lidocaine Transdermal Patch Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Lidocaine Transdermal Patch Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Lidocaine Transdermal Patch Sales by Country/Region (2020-2025) & (M Pcs)
Table 31. Global Lidocaine Transdermal Patch Sales Market Share by Country/Region (2020-2025)
Table 32. Global Lidocaine Transdermal Patch Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Lidocaine Transdermal Patch Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Lidocaine Transdermal Patch Sales by Country (2020-2025) & (M Pcs)
Table 35. Americas Lidocaine Transdermal Patch Sales Market Share by Country (2020-2025)
Table 36. Americas Lidocaine Transdermal Patch Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Lidocaine Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 38. Americas Lidocaine Transdermal Patch Sales by Application (2020-2025) & (M Pcs)
Table 39. APAC Lidocaine Transdermal Patch Sales by Region (2020-2025) & (M Pcs)
Table 40. APAC Lidocaine Transdermal Patch Sales Market Share by Region (2020-2025)
Table 41. APAC Lidocaine Transdermal Patch Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Lidocaine Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 43. APAC Lidocaine Transdermal Patch Sales by Application (2020-2025) & (M Pcs)
Table 44. Europe Lidocaine Transdermal Patch Sales by Country (2020-2025) & (M Pcs)
Table 45. Europe Lidocaine Transdermal Patch Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Lidocaine Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 47. Europe Lidocaine Transdermal Patch Sales by Application (2020-2025) & (M Pcs)
Table 48. Middle East & Africa Lidocaine Transdermal Patch Sales by Country (2020-2025) & (M Pcs)
Table 49. Middle East & Africa Lidocaine Transdermal Patch Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Lidocaine Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 51. Middle East & Africa Lidocaine Transdermal Patch Sales by Application (2020-2025) & (M Pcs)
Table 52. Key Market Drivers & Growth Opportunities of Lidocaine Transdermal Patch
Table 53. Key Market Challenges & Risks of Lidocaine Transdermal Patch
Table 54. Key Industry Trends of Lidocaine Transdermal Patch
Table 55. Lidocaine Transdermal Patch Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Lidocaine Transdermal Patch Distributors List
Table 58. Lidocaine Transdermal Patch Customer List
Table 59. Global Lidocaine Transdermal Patch Sales Forecast by Region (2026-2031) & (M Pcs)
Table 60. Global Lidocaine Transdermal Patch Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Lidocaine Transdermal Patch Sales Forecast by Country (2026-2031) & (M Pcs)
Table 62. Americas Lidocaine Transdermal Patch Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Lidocaine Transdermal Patch Sales Forecast by Region (2026-2031) & (M Pcs)
Table 64. APAC Lidocaine Transdermal Patch Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Lidocaine Transdermal Patch Sales Forecast by Country (2026-2031) & (M Pcs)
Table 66. Europe Lidocaine Transdermal Patch Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Lidocaine Transdermal Patch Sales Forecast by Country (2026-2031) & (M Pcs)
Table 68. Middle East & Africa Lidocaine Transdermal Patch Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Lidocaine Transdermal Patch Sales Forecast by Type (2026-2031) & (M Pcs)
Table 70. Global Lidocaine Transdermal Patch Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Lidocaine Transdermal Patch Sales Forecast by Application (2026-2031) & (M Pcs)
Table 72. Global Lidocaine Transdermal Patch Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Teikoku Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 74. Teikoku Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 75. Teikoku Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 76. Teikoku Main Business
Table 77. Teikoku Latest Developments
Table 78. Teva Pharmaceutical Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 79. Teva Pharmaceutical Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 80. Teva Pharmaceutical Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 81. Teva Pharmaceutical Main Business
Table 82. Teva Pharmaceutical Latest Developments
Table 83. Sorrento Therapeutics Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 84. Sorrento Therapeutics Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 85. Sorrento Therapeutics Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 86. Sorrento Therapeutics Main Business
Table 87. Sorrento Therapeutics Latest Developments
Table 88. Hisamitsu Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 89. Hisamitsu Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 90. Hisamitsu Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 91. Hisamitsu Main Business
Table 92. Hisamitsu Latest Developments
Table 93. Endo International Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 94. Endo International Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 95. Endo International Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 96. Endo International Main Business
Table 97. Endo International Latest Developments
Table 98. Par Pharmaceutical Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 99. Par Pharmaceutical Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 100. Par Pharmaceutical Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 101. Par Pharmaceutical Main Business
Table 102. Par Pharmaceutical Latest Developments
Table 103. Mylan Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 104. Mylan Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 105. Mylan Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 106. Mylan Main Business
Table 107. Mylan Latest Developments
Table 108. Tide Pharmaceutical (SINO BIOPHARM) Basic Information, Lidocaine Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 109. Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Product Portfolios and Specifications
Table 110. Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
Table 111. Tide Pharmaceutical (SINO BIOPHARM) Main Business
Table 112. Tide Pharmaceutical (SINO BIOPHARM) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Lidocaine Transdermal Patch
Figure 2. Lidocaine Transdermal Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lidocaine Transdermal Patch Sales Growth Rate 2020-2031 (M Pcs)
Figure 7. Global Lidocaine Transdermal Patch Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Lidocaine Transdermal Patch Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Lidocaine Transdermal Patch Sales Market Share by Country/Region (2024)
Figure 10. Lidocaine Transdermal Patch Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lidocare 5% Transdermal Patch
Figure 12. Product Picture of Lidocare 1.80% Transdermal Patch
Figure 13. Product Picture of Lidocare 4% Transdermal Patch
Figure 14. Global Lidocaine Transdermal Patch Sales Market Share by Type in 2025
Figure 15. Global Lidocaine Transdermal Patch Revenue Market Share by Type (2020-2025)
Figure 16. Lidocaine Transdermal Patch Consumed in Online Pharmacies
Figure 17. Global Lidocaine Transdermal Patch Market: Online Pharmacies (2020-2025) & (M Pcs)
Figure 18. Lidocaine Transdermal Patch Consumed in Hospital Pharmacies
Figure 19. Global Lidocaine Transdermal Patch Market: Hospital Pharmacies (2020-2025) & (M Pcs)
Figure 20. Lidocaine Transdermal Patch Consumed in Clinic
Figure 21. Global Lidocaine Transdermal Patch Market: Clinic (2020-2025) & (M Pcs)
Figure 22. Lidocaine Transdermal Patch Consumed in Monomer Pharmacies
Figure 23. Global Lidocaine Transdermal Patch Market: Monomer Pharmacies (2020-2025) & (M Pcs)
Figure 24. Lidocaine Transdermal Patch Consumed in Chain Pharmacies
Figure 25. Global Lidocaine Transdermal Patch Market: Chain Pharmacies (2020-2025) & (M Pcs)
Figure 26. Lidocaine Transdermal Patch Consumed in Other
Figure 27. Global Lidocaine Transdermal Patch Market: Other (2020-2025) & (M Pcs)
Figure 28. Global Lidocaine Transdermal Patch Sale Market Share by Application (2024)
Figure 29. Global Lidocaine Transdermal Patch Revenue Market Share by Application in 2025
Figure 30. Lidocaine Transdermal Patch Sales by Company in 2025 (M Pcs)
Figure 31. Global Lidocaine Transdermal Patch Sales Market Share by Company in 2025
Figure 32. Lidocaine Transdermal Patch Revenue by Company in 2025 ($ millions)
Figure 33. Global Lidocaine Transdermal Patch Revenue Market Share by Company in 2025
Figure 34. Global Lidocaine Transdermal Patch Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Lidocaine Transdermal Patch Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Lidocaine Transdermal Patch Sales 2020-2025 (M Pcs)
Figure 37. Americas Lidocaine Transdermal Patch Revenue 2020-2025 ($ millions)
Figure 38. APAC Lidocaine Transdermal Patch Sales 2020-2025 (M Pcs)
Figure 39. APAC Lidocaine Transdermal Patch Revenue 2020-2025 ($ millions)
Figure 40. Europe Lidocaine Transdermal Patch Sales 2020-2025 (M Pcs)
Figure 41. Europe Lidocaine Transdermal Patch Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Lidocaine Transdermal Patch Sales 2020-2025 (M Pcs)
Figure 43. Middle East & Africa Lidocaine Transdermal Patch Revenue 2020-2025 ($ millions)
Figure 44. Americas Lidocaine Transdermal Patch Sales Market Share by Country in 2025
Figure 45. Americas Lidocaine Transdermal Patch Revenue Market Share by Country (2020-2025)
Figure 46. Americas Lidocaine Transdermal Patch Sales Market Share by Type (2020-2025)
Figure 47. Americas Lidocaine Transdermal Patch Sales Market Share by Application (2020-2025)
Figure 48. United States Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Lidocaine Transdermal Patch Sales Market Share by Region in 2025
Figure 53. APAC Lidocaine Transdermal Patch Revenue Market Share by Region (2020-2025)
Figure 54. APAC Lidocaine Transdermal Patch Sales Market Share by Type (2020-2025)
Figure 55. APAC Lidocaine Transdermal Patch Sales Market Share by Application (2020-2025)
Figure 56. China Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 60. India Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 62. China Taiwan Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Lidocaine Transdermal Patch Sales Market Share by Country in 2025
Figure 64. Europe Lidocaine Transdermal Patch Revenue Market Share by Country (2020-2025)
Figure 65. Europe Lidocaine Transdermal Patch Sales Market Share by Type (2020-2025)
Figure 66. Europe Lidocaine Transdermal Patch Sales Market Share by Application (2020-2025)
Figure 67. Germany Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 68. France Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Lidocaine Transdermal Patch Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Lidocaine Transdermal Patch Sales Market Share by Type (2020-2025)
Figure 74. Middle East & Africa Lidocaine Transdermal Patch Sales Market Share by Application (2020-2025)
Figure 75. Egypt Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 78. Turkey Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Lidocaine Transdermal Patch in 2025
Figure 81. Manufacturing Process Analysis of Lidocaine Transdermal Patch
Figure 82. Industry Chain Structure of Lidocaine Transdermal Patch
Figure 83. Channels of Distribution
Figure 84. Global Lidocaine Transdermal Patch Sales Market Forecast by Region (2026-2031)
Figure 85. Global Lidocaine Transdermal Patch Revenue Market Share Forecast by Region (2026-2031)
Figure 86. Global Lidocaine Transdermal Patch Sales Market Share Forecast by Type (2026-2031)
Figure 87. Global Lidocaine Transdermal Patch Revenue Market Share Forecast by Type (2026-2031)
Figure 88. Global Lidocaine Transdermal Patch Sales Market Share Forecast by Application (2026-2031)
Figure 89. Global Lidocaine Transdermal Patch Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Lidocaine Transdermal Patch
Figure 2. Lidocaine Transdermal Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lidocaine Transdermal Patch Sales Growth Rate 2020-2031 (M Pcs)
Figure 7. Global Lidocaine Transdermal Patch Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Lidocaine Transdermal Patch Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Lidocaine Transdermal Patch Sales Market Share by Country/Region (2024)
Figure 10. Lidocaine Transdermal Patch Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lidocare 5% Transdermal Patch
Figure 12. Product Picture of Lidocare 1.80% Transdermal Patch
Figure 13. Product Picture of Lidocare 4% Transdermal Patch
Figure 14. Global Lidocaine Transdermal Patch Sales Market Share by Type in 2025
Figure 15. Global Lidocaine Transdermal Patch Revenue Market Share by Type (2020-2025)
Figure 16. Lidocaine Transdermal Patch Consumed in Online Pharmacies
Figure 17. Global Lidocaine Transdermal Patch Market: Online Pharmacies (2020-2025) & (M Pcs)
Figure 18. Lidocaine Transdermal Patch Consumed in Hospital Pharmacies
Figure 19. Global Lidocaine Transdermal Patch Market: Hospital Pharmacies (2020-2025) & (M Pcs)
Figure 20. Lidocaine Transdermal Patch Consumed in Clinic
Figure 21. Global Lidocaine Transdermal Patch Market: Clinic (2020-2025) & (M Pcs)
Figure 22. Lidocaine Transdermal Patch Consumed in Monomer Pharmacies
Figure 23. Global Lidocaine Transdermal Patch Market: Monomer Pharmacies (2020-2025) & (M Pcs)
Figure 24. Lidocaine Transdermal Patch Consumed in Chain Pharmacies
Figure 25. Global Lidocaine Transdermal Patch Market: Chain Pharmacies (2020-2025) & (M Pcs)
Figure 26. Lidocaine Transdermal Patch Consumed in Other
Figure 27. Global Lidocaine Transdermal Patch Market: Other (2020-2025) & (M Pcs)
Figure 28. Global Lidocaine Transdermal Patch Sale Market Share by Application (2024)
Figure 29. Global Lidocaine Transdermal Patch Revenue Market Share by Application in 2025
Figure 30. Lidocaine Transdermal Patch Sales by Company in 2025 (M Pcs)
Figure 31. Global Lidocaine Transdermal Patch Sales Market Share by Company in 2025
Figure 32. Lidocaine Transdermal Patch Revenue by Company in 2025 ($ millions)
Figure 33. Global Lidocaine Transdermal Patch Revenue Market Share by Company in 2025
Figure 34. Global Lidocaine Transdermal Patch Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Lidocaine Transdermal Patch Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Lidocaine Transdermal Patch Sales 2020-2025 (M Pcs)
Figure 37. Americas Lidocaine Transdermal Patch Revenue 2020-2025 ($ millions)
Figure 38. APAC Lidocaine Transdermal Patch Sales 2020-2025 (M Pcs)
Figure 39. APAC Lidocaine Transdermal Patch Revenue 2020-2025 ($ millions)
Figure 40. Europe Lidocaine Transdermal Patch Sales 2020-2025 (M Pcs)
Figure 41. Europe Lidocaine Transdermal Patch Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Lidocaine Transdermal Patch Sales 2020-2025 (M Pcs)
Figure 43. Middle East & Africa Lidocaine Transdermal Patch Revenue 2020-2025 ($ millions)
Figure 44. Americas Lidocaine Transdermal Patch Sales Market Share by Country in 2025
Figure 45. Americas Lidocaine Transdermal Patch Revenue Market Share by Country (2020-2025)
Figure 46. Americas Lidocaine Transdermal Patch Sales Market Share by Type (2020-2025)
Figure 47. Americas Lidocaine Transdermal Patch Sales Market Share by Application (2020-2025)
Figure 48. United States Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Lidocaine Transdermal Patch Sales Market Share by Region in 2025
Figure 53. APAC Lidocaine Transdermal Patch Revenue Market Share by Region (2020-2025)
Figure 54. APAC Lidocaine Transdermal Patch Sales Market Share by Type (2020-2025)
Figure 55. APAC Lidocaine Transdermal Patch Sales Market Share by Application (2020-2025)
Figure 56. China Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 60. India Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 62. China Taiwan Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Lidocaine Transdermal Patch Sales Market Share by Country in 2025
Figure 64. Europe Lidocaine Transdermal Patch Revenue Market Share by Country (2020-2025)
Figure 65. Europe Lidocaine Transdermal Patch Sales Market Share by Type (2020-2025)
Figure 66. Europe Lidocaine Transdermal Patch Sales Market Share by Application (2020-2025)
Figure 67. Germany Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 68. France Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Lidocaine Transdermal Patch Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Lidocaine Transdermal Patch Sales Market Share by Type (2020-2025)
Figure 74. Middle East & Africa Lidocaine Transdermal Patch Sales Market Share by Application (2020-2025)
Figure 75. Egypt Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 78. Turkey Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Lidocaine Transdermal Patch Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Lidocaine Transdermal Patch in 2025
Figure 81. Manufacturing Process Analysis of Lidocaine Transdermal Patch
Figure 82. Industry Chain Structure of Lidocaine Transdermal Patch
Figure 83. Channels of Distribution
Figure 84. Global Lidocaine Transdermal Patch Sales Market Forecast by Region (2026-2031)
Figure 85. Global Lidocaine Transdermal Patch Revenue Market Share Forecast by Region (2026-2031)
Figure 86. Global Lidocaine Transdermal Patch Sales Market Share Forecast by Type (2026-2031)
Figure 87. Global Lidocaine Transdermal Patch Revenue Market Share Forecast by Type (2026-2031)
Figure 88. Global Lidocaine Transdermal Patch Sales Market Share Forecast by Application (2026-2031)
Figure 89. Global Lidocaine Transdermal Patch Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Intelligent Wheelchair Market Growth 2024-2030
US$ 3,660.00
August 2024
109 pages
Global Blood Purification Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
103 pages
Global Probiotic Pills Market Growth 2024-2030
US$ 3,660.00
October 2024
102 pages
Global 3D Cell Culture Market Growth 2025-2031
US$ 3,660.00
March 2025
106 pages
Global Meniscal Repair System Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
87 pages
